tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Evolent Health: Overly Pessimistic Valuation Presents a Buy Opportunity Amidst Exaggerated Concerns
PremiumRatingsEvolent Health: Overly Pessimistic Valuation Presents a Buy Opportunity Amidst Exaggerated Concerns
2M ago
Evolent Health price target lowered to $7 from $13 at JPMorgan
Premium
The Fly
Evolent Health price target lowered to $7 from $13 at JPMorgan
2M ago
Evolent Health price target lowered to $9 from $16 at Canaccord
Premium
The Fly
Evolent Health price target lowered to $9 from $16 at Canaccord
2M ago
BMO Capital’s Optimistic Buy Rating for Evolent Health Driven by Strategic Stabilization and Growth Initiatives
PremiumRatingsBMO Capital’s Optimistic Buy Rating for Evolent Health Driven by Strategic Stabilization and Growth Initiatives
2M ago
Evolent Health initiated with an Outperform at BMO Capital
Premium
The Fly
Evolent Health initiated with an Outperform at BMO Capital
2M ago
Evolent Health price target lowered to $12 from $18 at Oppenheimer
Premium
The Fly
Evolent Health price target lowered to $12 from $18 at Oppenheimer
2M ago
Evolent Health: Strategic Growth Potential Amidst Near-Term Challenges
PremiumRatingsEvolent Health: Strategic Growth Potential Amidst Near-Term Challenges
2M ago
Evolent Health Announces Leadership Changes Amid Growth
Premium
Company Announcements
Evolent Health Announces Leadership Changes Amid Growth
2M ago
Evolent Health sees Q4 revenue $462M-$472M, consensus $472.55M
Premium
The Fly
Evolent Health sees Q4 revenue $462M-$472M, consensus $472.55M
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100